Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
Swiss-Belhotel International has announced ambitious expansion plans with a strategic focus on Central and Southeast Asia, the Middle East and Africa. As part of the move the group recently signed a memorandum of understanding (MOU) Read More